Related Experiment Video
Updated: Jul 10, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Mycophenolate mofetil: effects on clinical transplantation
C D Holt1, T M Sievers, R M Ghobrial
1Department of Surgery, Division of Liver and Pancreas Transplantation, UCLA Medical Center, Los Angeles, California, USA.
Summary
Mycophenolate mofetil (MMF) is an immunosuppressant drug that inhibits lymphocyte proliferation. It is approved for preventing kidney transplant rejection and shows promise in treating refractory rejection in various organ transplants.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Background:
- Mycophenolate mofetil (MMF) is a prodrug of mycophenolic acid.
- Mycophenolic acid inhibits lymphocyte proliferation by targeting inosine monophosphate dehydrogenase.
- This enzyme is crucial for the de novo synthesis of guanosine nucleotides.
Purpose of the Study:
- To summarize the current applications and efficacy of MMF in transplantation.
Main Methods:
- Review of existing clinical studies and approved indications for MMF.
- Analysis of MMF's mechanism of action in inhibiting lymphocyte proliferation.
Main Results:
- MMF is approved for preventing acute renal allograft rejection when combined with cyclosporine and corticosteroids.
- Studies indicate MMF's effectiveness in managing refractory rejection in renal, heart, and liver transplant recipients.
Conclusions:
- MMF is a valuable immunosuppressant for preventing and treating rejection in organ transplantation.
- Its mechanism of action provides a targeted approach to managing immune responses post-transplant.
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:40Cell-mediated Immune Responses
Overview
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.